Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)

SHA:605016 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	325.52	286.84	175.87	191.69	305.24	141.36
Trading Asset Securities	201.29	152.27	252.7	330	248.35	-
Cash & Short-Term Investments	526.81	439.11	428.57	521.69	553.59	141.36
Cash Growth	6.78%	2.46%	-17.85%	-5.76%	291.63%	67.24%
Accounts Receivable	236.04	231.44	169.43	152.63	143.62	127
Other Receivables	15.8	9.46	4.85	2.21	1.45	1.64
Receivables	251.83	240.9	174.27	154.83	145.07	128.64
Inventory	215.54	186.83	152.05	167.71	121.82	90.03
Prepaid Expenses	-	-	0.12	0.11	-	0.04
Other Current Assets	56.58	34.63	18.72	11.19	11.41	14.21
Total Current Assets	1,051	901.46	773.74	855.54	831.89	374.27
Property, Plant & Equipment	976.66	987.82	854.02	500.99	370.5	379.17
Long-Term Investments	60.88	60.88	58.98	58.9	57.17	55.2
Other Intangible Assets	16.92	17.58	14.19	14.74	15.31	15.99
Long-Term Deferred Tax Assets	6.74	6.74	2.39	2.58	2.57	2.37
Long-Term Deferred Charges	11.09	12.14	2.42	1.23	1.78	8.22
Other Long-Term Assets	54.74	26.88	48.45	37.96	3.29	0.76
Total Assets	2,178	2,014	1,754	1,472	1,283	836
Accounts Payable	172	242.81	214.89	93.34	46.05	52.37
Accrued Expenses	18.3	14.92	15.83	17.11	13.49	9.12
Short-Term Debt	150	10	-	-	1	68.5
Current Portion of Long-Term Debt	-	1.18	-	-	-	-
Current Portion of Leases	1.55	-	1.03	1.1	0.74	-
Current Income Taxes Payable	32.29	19.47	6.9	5.33	2.9	2.17
Current Unearned Revenue	12.62	3.51	2.89	4.07	6.89	3.11
Other Current Liabilities	-	10.56	0.15	0.15	0.15	0.41
Total Current Liabilities	386.77	302.45	241.7	121.11	71.21	135.68
Long-Term Leases	0.37	1.02	0.63	0.35	0.78	-
Long-Term Unearned Revenue	27.11	27.92	1.41	2.97	4.76	7.22
Long-Term Deferred Tax Liabilities	2.89	2.89	2.62	2.58	2.31	2.01
Total Liabilities	417.13	334.27	246.35	127.01	79.05	144.91
Common Stock	323.09	323.09	248.53	177.52	126.8	95
Additional Paid-In Capital	434.23	434.23	508.79	579.8	630.52	256.1
Retained Earnings	987.12	905.7	735.91	573.09	433.08	328.6
Comprehensive Income & Other	16.22	16.22	14.6	14.54	13.06	11.39
Shareholders' Equity	1,761	1,679	1,508	1,345	1,203	691.09
Total Liabilities & Equity	2,178	2,014	1,754	1,472	1,283	836
Total Debt	151.91	12.2	1.66	1.45	2.52	68.5
Net Cash (Debt)	374.89	426.91	426.91	520.24	551.07	72.86
Net Cash Growth	-12.75%	-0.00%	-17.94%	-5.59%	656.39%	137.93%
Net Cash Per Share	1.09	1.32	1.33	1.62	1.86	0.30
Filing Date Shares Outstanding	325.68	323.09	323.09	323.09	323.09	242.06
Total Common Shares Outstanding	325.68	323.09	323.09	323.09	323.09	242.06
Working Capital	663.99	599.01	532.04	734.43	760.68	238.59
Book Value Per Share	5.41	5.20	4.67	4.16	3.72	2.86
Tangible Book Value	1,744	1,662	1,494	1,330	1,188	675.1
Tangible Book Value Per Share	5.35	5.14	4.62	4.12	3.68	2.79
Buildings	-	-	180.6	158.6	162.18	154.78
Machinery	-	-	433.86	417.39	415.03	395.68
Construction In Progress	-	-	522.23	193.36	17.12	9.04

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.